Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. 

Highlighted with 88 tables and 111 figures, this 193-page report “Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure 

• Growth Drivers 

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Region. 

Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Small Molecules

• Large Molecules

o LC-MS Studies 

o Immunoassays 

o Other Large Molecule Tests

Based Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Bioavailability and Bioequivalence Studies

• Pharmacokinetics (PK)

• Pharmacodynamics (PD)

• Absorption, Distribution, Metabolism, Excretion (ADME)

• Other Applications

By Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Cell-based Assays

o Bacterial Cell-based Assays

o Viral Cell-based Assays

• Virology Testing

o In Vitro Virology Testing

o In Vivo Virology Testing

o Species-Specific Viral PCR Assays

• Serology, Immunogenicity, and Neutralizing Antibodies (SINA)

o Bacterial Serology, Immunogenicity, and Neutralizing Antibodies

o Viral Serology, Immunogenicity, and Neutralizing Antibodies

• Method Development Optimization and Validation (MDOV)

• Biomarker Testing

• Pharmacokinetic Testing

• Other Test Types

By Workflow Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Sample Preparation

o Protein Precipitation

o Liquid-liquid Extraction (LLE)

• Sample Analysis

o Hyphenated Technique

o Chromatographic Technique

o Electrophoresis

o Ligand Binding Assay

o Mass Spectrometry

o Nuclear Magnetic Resonance

• Other Workflow Processes

By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Oncology

• Neurology

• Infectious Diseases

• Gastroenterology

• Cardiology

• Other Therapeutic Areas

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Pharma and Biopharma Companies

• Contract Development and Manufacturing Organizations (CDMOs)

• Contract Research Organizations (CROs)

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)

• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

• South America (Brazil, Chile, Argentina, Rest of South America)

• MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players: 

Charles River Laboratories International Inc.

Covance Inc.

Eurofins Scientific

ICON PLC

Intertek Group PLC

IQVIA Holdings, Inc.

Laboratory Corporation of America Holdings

Medpace Holdings, Inc.

Pace Analytical Services LLC.

Parexel International Corporation

PPD Inc.

SGS SA

Syneos Health, LLC

Toxikon Corporation

WuXi Apptech Co., Ltd. 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)